BDBM482295 US10919843, Compound IV

SMILES: CCCCCC1=C(NCC(C)C)C(=O)C([C@@H]2C=C(C)CC[C@H]2C(C)=C)=C(O)C1=O

InChI Key: InChIKey=OINCHLNUXZXNDV-AZUAARDMSA-N

Data: 2 EC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 482295   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Hypoxia-inducible factor 1-alpha (Homo sapiens (Human))	BDBM482295 (US10919843, Compound IV) Show SMILES CCCCCC1=C(NCC(C)C)C(=O)C([C@@H]2C=C(C)CC[C@H]2C(C)=C)=C(O)C1=O |r,c:5,t:16,25| Show InChI InChI=1S/C25H37NO3/c1-7-8-9-10-19-22(26-14-15(2)3)24(28)21(25(29)23(19)27)20-13-17(6)11-12-18(20)16(4)5/h13,15,18,20,26,29H,4,7-12,14H2,1-3,5-6H3/t18-,20+/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	1.60E+3	n/a	n/a	n/a	n/a
Emerald Health Pharmaceuticals Inc. US Patent					Assay Description HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...				US Patent US10919843 (2021)
					More data for this Ligand-Target Pair
Hypoxia-inducible factor 1-alpha (Homo sapiens (Human))	BDBM482295 (US10919843, Compound IV) Show SMILES CCCCCC1=C(NCC(C)C)C(=O)C([C@@H]2C=C(C)CC[C@H]2C(C)=C)=C(O)C1=O |r,c:5,t:16,25| Show InChI InChI=1S/C25H37NO3/c1-7-8-9-10-19-22(26-14-15(2)3)24(28)21(25(29)23(19)27)20-13-17(6)11-12-18(20)16(4)5/h13,15,18,20,26,29H,4,7-12,14H2,1-3,5-6H3/t18-,20+/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	3.20E+3	n/a	n/a	n/a	n/a
Emerald Health Pharmaceuticals Inc. US Patent					Assay Description NIH3T3-EPO-luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and...				US Patent US10919843 (2021)
					More data for this Ligand-Target Pair